By entering this site, you acknowledge that all products and information are provided for research purposes only and are not intended for human consumption or medical use.
You must be 21 years of age or older to use this website.
Each vial ships with structural data and lot identifiers for the compound, plus a Certificate of Analysis documenting purity and identity. Ready for the bench. Synthesized via solid-phase peptide synthesis (SPPS), purified by reverse-phase HPLC, verified by mass spectrometry, and tested for sterility and endotoxin load. Every spec is documented on the signed Certificate of Analysis that ships with your vial.
Semaglutide is a 31-amino acid GLP-1 receptor agonist structurally derived from native glucagon-like peptide-1 (GLP-1), with a C18 fatty acid chain attached via a linker to lysine-26 enabling albumin binding and extended plasma half-life.
In research models, semaglutide activates GLP-1 receptors in the pancreas (glucose-dependent insulin secretion and glucagon suppression), gut (gastric emptying modulation), and CNS (hypothalamic and brainstem satiety signaling pathways). Published research has examined receptor pathway activity and metabolic signaling associated with this mechanism.
This product is for laboratory research use only. Not for human administration. Not intended to diagnose, treat, cure, or prevent any disease.
Marso SP, et al. · N Engl J Med
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
PubMed · PubMed · 27295427Wilding JPH, et al. · N Engl J Med
Once-Weekly Semaglutide in Adults with Overweight or Obesity
PubMed · PubMed · 3356718510mg / single compound
10mg / single compound
10mg / single compound
30-day money back · Free shipping over $150 · 2-day shipping
[search_result]
Frequently Bought Together